Welcome to our dedicated page for Exponent news (Ticker: EXPO), a resource for investors and traders seeking the latest updates and insights on Exponent stock.
Exponent Inc reports developments in science and engineering consulting, including financial results, client demand across its two operating segments, and capital-return actions. Its engineering and other scientific work includes failure analysis, dispute-related consulting, user research for consumer electronics, utility risk management, asset integrity, transportation, energy, construction, life sciences, and medical device support.
The company’s environmental and health segment is tied to chemical regulation, food safety, ecological and biological sciences, and environmental consulting. Recurring updates also cover quarterly dividends, share repurchase authorizations, conference calls, executive appointments, board matters, and governance changes.
Exponent (Nasdaq: EXPO) reported Q1 FY2026 results for the period ended April 3, 2026. Total revenues rose 14% to $166.3M and revenues before reimbursements rose 10% to $151.8M. Net income was $29.6M, or $0.59 diluted per share.
EBITDA was $43.1M (28.4% of net revenues). The company paid $16.6M in dividends, repurchased $78.8M of stock, ended the quarter with $118.6M cash, raised its buyback authorization by $50M, and maintained full-year guidance (high-single-digit revenue growth; EBITDA 27.6%–28.1% of revenues before reimbursements).
Exponent (Nasdaq: EXPO) declared a quarterly cash dividend of $0.31 per share, payable on June 18, 2026 to shareholders of record as of June 5, 2026. The company reaffirmed its quarterly cadence (March, June, September, December).
In addition, the Board increased the share repurchase authorization by $50 million, supplementing $17.7 million available as of April 3, 2026. Management cited profitability and a strong balance sheet as support for continued capital returns.
Exponent (Nasdaq: EXPO) will report First Quarter fiscal 2026 results for the period ended April 3, 2026 after market close on Thursday, April 30, 2026.
Dr. Catherine Corrigan, CEO and President, and Richard Schlenker, EVP and CFO, will host a conference call and webcast at 4:30 p.m. ET / 1:30 p.m. PT. Live dial-in numbers, a live and archived webcast, and a telephonic replay through May 7, 2026 are provided for investors.
Exponent (Nasdaq:EXPO) announced leadership changes effective May 1, 2026 and at the Annual Meeting on June 4, 2026: John Pye named President, Eric Anderson named Chief Financial Officer, Richard Schlenker to remain Executive VP and stand for election to the Board, and Karen Richardson to become Board Chair upon Paul Johnston’s retirement.
All appointments are internal promotions reflecting continuity in technical and financial leadership.
Exponent (Nasdaq: EXPO) announced a quarterly cash dividend increase from $0.30 to $0.31 per share for Q1 2026. The dividend will be paid on March 20, 2026 to holders of record as of March 6, 2026. Exponent intends to continue regular quarterly dividends each March, June, September, and December, with future declarations subject to Board approval.
Exponent (Nasdaq: EXPO) reported Q4 and fiscal 2025 results: Q4 revenue $147.4M (+7.8% vs. prior-year quarter) and FY revenue $582.0M (+4.2% vs. prior year). Q4 net income was $24.8M ($0.49 diluted EPS); FY net income was $106.0M ($2.07 diluted EPS). EBITDA for FY 2025 was $148.1M (27.6% of revenues before reimbursements). The board raised the quarterly cash dividend to $0.31 payable March 20, 2026, and the company repurchased $97.8M of common stock during the year.
Management expects high-single-digit revenue growth for Q1 and full-year 2026 and FY EBITDA margin around 27.6%–28.1% of revenues before reimbursements.
Exponent (Nasdaq: EXPO) declared a quarterly cash dividend of $0.30 per share, payable on December 19, 2025 to stockholders of record as of December 5, 2025. The company expects to continue quarterly dividends in March, June, September, and December, subject to Board approval.
Separately, the Board increased the share repurchase authorization by $100 million, adding to the $21.6 million available for repurchase as of October 3, 2025. Management cited strong cash flow and balance sheet strength as the rationale for these capital-allocation actions.
Exponent (Nasdaq: EXPO) reported third-quarter fiscal 2025 results for the period ended October 3, 2025. Q3 revenues rose 8% to $147.1M and revenues before reimbursements rose 10% to $137.1M. Net income was $28.0M, or $0.55 diluted EPS. EBITDA was $38.8M (28.3% of revenues before reimbursements). Year-to-date revenues rose 3% to $434.6M while net income decreased to $81.2M. The company paid $46.7M in dividends, repurchased $72.7M of stock, and ended the period with $207.4M cash. The Board approved a $100M increase to the buyback program and declared a $0.30 quarterly dividend.
Q4 and full-year 2025 guidance includes modest revenue growth and EBITDA margin ranges of 26.0%–27.0% (Q4) and 27.4%–27.65% (full year).
Exponent (Nasdaq: EXPO) will report Third Quarter fiscal 2025 results for the period ended October 3, 2025 after market close on Thursday, October 30, 2025. A conference call and webcast with CEO Dr. Catherine Corrigan and EVP/CFO Richard Schlenker will be held at 4:30 p.m. ET / 1:30 p.m. PT on the same day to discuss business and financial results.
Investors can join live by dialing (844) 481-2781 or (412) 317-0672, or listen via a live and archived webcast at the company Investor Relations site. A telephonic replay is available through Thursday, November 6, 2025 at (877) 344-7529 or (412) 317-0088 with passcode 1587971#.
Exponent (NASDAQ: EXPO) has declared a quarterly cash dividend of $0.30 per share for Q3 2025. The dividend will be paid on September 19, 2025, to stockholders of record as of September 5, 2025.
The company maintains its regular quarterly dividend schedule in March, June, September, and December. CEO Dr. Catherine Corrigan emphasized the company's commitment to shareholder returns and highlighted Exponent's strong market position in safety, health, and environmental services.